Pseudoepitheliomatous hyperplasia (PEH), a neglected entity by oral pathologist possesses utmost importance in the field of research. Of all the investigative challenges, PEH, a reactive epithelial proliferation is seen secondary to lesions with infectious, inflammatory, reactive, and degenerative origin. Small sized samples, incomplete excision, improper orientation, and dense inflammatory changes render diagnostic confront to the oral pathologist in exclusion of frankly invasive malignant lesions like squamous cell carcinoma from lesions exhibiting PEH. The diagnosis can occasionally be difficult as they mimic other lesions also, on clinic-pathological assessment. Thus, this article gives an insight regarding the various concepts of etiopathogenesis, histopathology, differential diagnosis, and malignant potential of PEH. A combined effort of a clinician and pathologist benefits every patient to rule out malignancy and render appropriate treatment as the only local conservative approach is essential to remove PEH associated lesions.
Introduction
Pseudoepitheliomatous hyperplasia (PEH) is considered to be a "benign proliferation of the epidermis into irregular squamous strands extending down into the dermis, respectively, 1 with no cytological atypia and mitotic figures."
2 Dr. Unna (1896) brought to light the first case of PEH as "Epidermal proliferation overlying a lesion of Lupus Vulgaris." This lesion is also referred as pseudocarcinomatous hyperplasia 3 (as they mimic squamous cell carcinoma [SCC]) 4 and invasive epidermal hyperplasia, invasive acanthosis, verrucous epidermal hyperplasia, and carcinomatous hyperplasia. 5 Clinically, these wounds appear as skin ulcers/wounds, verrucous/multinodular growth, cauliflower growths, and dome-shaped swelling with smooth/warty surfaces. 5 This reactive proliferation of the epithelium occurs secondary to persistent inflammation resulting from the chronic traumatic wound, ulcer, bacterial/fungal infection, degenerative changes, retained foreign material, dermatitis, traumatic implantation of epithelium, and malignancy. 2, 5 Lesions exhibiting PEH are differentiated by the gold standard of biopsy from invasive malignant lesions. PEH is a benign lesion requiring only local conservative excision while malignant lesion needs radical surgery. As this entity is neglected among pathologist, this article is written in view to enlighten the target readers to set apart his condition from all malignant lesions.
Pathogenesis
PEH is a histopathological pattern rather than disease entity sui generis. 6 Pathologically, PEH arises due to the release of various cytokines produced by the tumor cells or inflammatory cells subsequently resulting in the proliferation of the overlying epithelium. Normally, any physical/chemical injury outcome is inflammation followed by the removal of devitalized tissue in the first few hours. Later, as a part of body's host immune response, the proliferation of connective tissue by fibroblast and vascular tissue growth occur. Finally, re-epithelization followed by fibrous maturation presents.
7
Any interruption in this process outcome is a disorderly arrangement of normal epithelial architecture exhibiting PEH. Pathogenesis of individual lesions exhibiting PEH is illustrated with underlying mechanism in Table 1 . 8 Stages of differentiation in PEH include (a) Acanthosis of the overlying epithelium (b) Acanthosis and dyskeratosis, and (c) PEH.
9
Mechanism of PEH PEH is a reactive process of epithelial proliferation of mucous and cutaneous surface epithelium. Although literature underlying the basic mechanism of this PEH suggests various reasons, the three most commonly observed factors are (1) Pseudopods of acanthotic epithelium observed in tangential sections wherein the epithelium appear to have invaded in isolated nests mimic malignancy (2) Regeneration of epithelium over the surface of viable tissue and ulcersdownward growth of epithelium into the underlying dermis (c) Traumatic implantation of epidermis. 10 Broadly, this particular lesion depending on the type of cellular origin could be classified as basal cell origin or squamous cell origin mimicking basal cell carcinoma or SCC, respectively.
5

Histopathology
Histopathologically, PEH appears with one or more of the following features: A close look at these features is definitely mandatory to differentiate prickle cell proliferation of the normal epithelium from SCC. 
Histological grading -PEH
White and Weidman (1926) described histological grades of PEH into three types.
11
Grade I: Hyperplasia, acanthosis, elongation of rete ridges to sweat glands, intact basement membrane.
Grade II: Noticeable proliferation of the rete ridges and extension deeper, irregular inter papillary projections, indefinite basement membrane, cells epithelial down growth assumes embryonic character.
Grade III: Mixture of irregular extensions of the epithelial down growth with the granulomatous formation, embryonic cell character. Appearance similar to well differentiated SCC.
Lesions Exhibiting PEH
This PEH can be encountered in a number of clinically diverse diseases. 6 The given chart (Table 2) 5,12-15 exhibits various lesions showing the evidence of PEH, some of which mimicking malignant lesions. In these lesions, a deep biopsy with culture study should be recommended to the clinician as superficial biopsy with insufficient connective tissue portion is difficult to rule out SCC. On observing the histopathological picture with laboratory findings and clinical features, a definitive diagnosis is formulated. 
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Variants of PEH Atypical PEH Atypical PEH is lesion similar to PEH exhibiting an epidermal proliferation deep into the underlying soft and hard tissue. Particularly, these lesions lack cytologic atypia (nuclear atypia/ abnormal mitosis/vascular invasion) as SCC.
2
Intraosseous PEH
Intraosseous PEH is a rare complication of fistulated chronic osteomyelitis of long bones. They arise as the epithelial structure of gum/periodontium (osteomyelitis). These lesions may sometimes be known with additional terminology as "atypical" due to its bone involvement. As there exists a difference in treatment modalities, PEH has to be sufficiently differentiated from SCC.
Histologically, intraosseous PEH shows proliferating squamous epithelium into medullary spaces without stromal intervention. The basal cell layer is particular oriented opposite to the bony trabeculae surrounding a fibrovascular core. Occasionally, spongiotic non-keratinizing epithelium with an inflammatory cell infiltrate also may be seen. Lesions also reveal a lack of cytological and nuclear atypia. In contrast to intraosseous PEH, SCC exhibits abundant tumor islands in the centro-medullary area surrounded by stroma. Sometimes, SCC may invade into the underlying bone.
16,17
Primary gingival PEH The first case of primary gingival PEH was observed by Elzay and O'Keefe, 1979. Histopathologically, hyperplastic stratified squamous epithelium with acanthosis is seen with surrounding chronic inflammatory cells. Absence of granular cells/mycotic organisms and other conditions associated with gingival growth. Absence of epithelial dysplasia rules out malignancy.
18,19
Does a pseudoepitheliomatous lesion turn malignant? Although various theories have been formulated, the exact pathogenesis of PEH is completely still unclear, but this occurrence should be based in mind not to over-diagnose the proliferating epithelium as SCC due to small and superficial biopsies. The malignant potential of PEH lesions is controversial. Literature has shown that few of such lesions turn malignant when they follow one or more of the following theories of potential malignancy. 4 It is mandatory to differentiate lesions with PEH from SCC as a treatment for a malignancy involves radical surgery/amputation 3 whereas wait and watch policy throughout life is necessary to observe the behavior of PEH lesions.
• Activated keratinocyte theory -Mitotically active keratinocytes proliferate rapidly on stimulation by inflammation from chronic wound dermis • Changes in the dermis -Abundant hyalinized, fibrinoid collagen and increased fibronectin production -abnormal metabolic activity in keratinocytes
• Altered immune system -Abnormal mitotic events (continued mitotic activity by re-epithelializing cells) undetected by the immune system.
Recent studies have shown that at the genetic level, formalin and paraffin fixed tissue exhibit C15 or F48 and KRT 9 distinctly elevated in SCC than PEH. 20 The research also has persuaded the scientist to bring out the multiplex TaqMan polymerase chain reaction (PCR) assay, an ancillary molecular diagnostic tool to distinguish PEH from SCC. This TaqMan PCR assay provides a scientific kit to differentiate SCC from PEH and identification of prognostic markers and molecular pathways as targets for the treatment of cutaneous SCC. 21 
Differential Diagnosis
Few infective to largely invasive malignant neoplasms appear as a differential diagnosis of PEH. The given Table 3 6,12-14,17, [22] [23] [24] [25] [26] [27] [28] [29] [30] gives a brief idea regarding various test utilized in their differentiation. Lesions (PEH) mimicking SCC and other related lesions.
Conclusion
PEH is a benign epithelial proliferation identified microscopically in association with various heterogeneous lesions. The pathogenesis of PEH is still unclear; however, a systematic knowledge of PEH is essential to rule out neoplasms. Clinicopathologic correlation remains a gold standard to reach the exact diagnosis. Small sized tissues, improper orientation, and dense inflammations in various lesions exhibiting PEH is challenging for pathologists to differentiate them from frank most aggressive lesions like SCC. Adequate excision and sampling depth render in exclusion of frankly malignant lesions and aid in appropriate treatment to the patient. Collaboration between clinician and pathologist is absolutely essential to deliver suitable treatment to the patient and avoid undesirable consequences.
